[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:probable-global-transcription-activator-snf2l2":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Probable Global Transcription Activator SNF2L2",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05687136","Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:17:30.145302Z","2026-07-05T05:32:16.811559Z"]